We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$127B
1-Year Est. Return
44.11%
This Fund
S&P 500
This Quarter
Est. Return
-14.27%
1 Year Est. Return
+44.11%
3 Year Est. Return
+121.64%
5 Year Est. Return
+154.22%
10 Year Est. Return
+724.54%
AUM
$123B
AUM Growth
-$24.7B
(-17%)
Cap. Flow
-$418M
Cap. Flow
% of AUM
-0.34%
Top 10 Holdings %
Top 10 Hldgs %
30.06%
Holding
304
New
10
Increased
88
Reduced
149
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America
BAC
|
+$485M |
| 2 |
HES
Hess
HES
|
+$460M |
| 3 |
Wells Fargo
WFC
|
+$356M |
| 4 |
Albemarle
ALB
|
+$291M |
| 5 |
Linde
LIN
|
+$226M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$468M |
| 2 |
Dell
DELL
|
+$283M |
| 3 |
Adobe
ADBE
|
+$261M |
| 4 |
PX
Praxair Inc
PX
|
+$231M |
| 5 |
NetApp
NTAP
|
+$193M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.09% |
| 2 | Healthcare | 25.96% |
| 3 | Industrials | 15.65% |
| 4 | Financials | 9.32% |
| 5 | Consumer Discretionary | 8.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Prestige Consumer Healthcare
PBH
$2.6B
| $868K | ﹤0.01% |
28,100
-10,400
| -27% | -$379K |
|
|
VLRS
277
Controladora Vuela Compania de Aviacion
VLRS
$939M
| $754K | ﹤0.01% |
140,900
-1,100
| -0.8% | -$6.99K |
|
|
DBD
278
DELISTED
Diebold Nixdorf Incorporated
DBD
| $747K | ﹤0.01% |
300,000
-375,000
| -56% | -$1.34M |
|
279
Garrett Motion
GTX
$5.57B
| $607K | ﹤0.01% |
+49,158
| New | +$668K |
|
280
Performance Food Group
PFGC
$18B
| $358K | ﹤0.01% |
11,100
| – | – |
|
|
DCOY
281
Decoy Therapeutics
DCOY
$2.09M
| – | – |
0
| – | – |
|
282
Booz Allen Hamilton
BAH
$9.15B
| – | – |
-139,750
| Closed | -$6.94M |
|
283
Chubb
CB
$135B
| – | – |
-41,133
| Closed | -$5.5M |
|
284
Cabot Corp
CBT
$4.52B
| – | – |
-125,000
| Closed | -$7.84M |
|
285
CNA Financial
CNA
$14.1B
| – | – |
-60,500
| Closed | -$2.76M |
|
286
Kirby Corp
KEX
$6.93B
| – | – |
-3,000
| Closed | -$247K |
|
287
Moody's
MCO
$82.7B
| – | – |
-30,200
| Closed | -$5.05M |
|
288
Range Resources
RRC
$8.95B
| – | – |
-1,050,000
| Closed | -$17.8M |
|
289
ExxonMobil
XOM
$634B
| – | – |
-50,000
| Closed | -$4.25M |
|
|
COL
290
DELISTED
Rockwell Collins
COL
| – | – |
-50,000
| Closed | -$7.02M |
|
|
PX
291
DELISTED
Praxair Inc
PX
| – | – |
-1,439,669
| Closed | -$231M |
|
|
DXTR
292
DELISTED
Dextera Surgical Inc.
DXTR
| – | – |
-600,450
| Closed | -$18K |
|
|
REXX
293
DELISTED
Rex Energy Corporation
REXX
| – | – |
-111,400
| Closed | -$7K |
|
Similar funds
VAM
Primecap Management's Q4 2018 Portfolio in Review
As of Q4 2018, Primecap Management held 304 positions worth $123B, down 17% from $148B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Primecap Management's Q4 2018 filing shows 10 new, 88 increased, 149 reduced and 13 closed positions. Its largest new stake was Linde: 1,431,369 shares worth $223M. The largest sale was Eli Lilly, an estimated $468M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 31% a quarter earlier, followed by Healthcare and Industrials.
- Primecap Management's largest Q4 2018 buy was Linde: 1,431,369 shares worth $223M.
- Primecap Management added most to Bank of America in Q4 2018, an estimated $485M increase.
- Primecap Management's biggest Q4 2018 reduction was Eli Lilly, cutting an estimated $468M.
- Primecap Management fully exited Praxair Inc in Q4 2018, selling an estimated $231M.
- Primecap Management's ten largest holdings make up 30% of its $123B portfolio in Q4 2018.
- Primecap Management opened 10 new positions and closed 13 in Q4 2018.
- Primecap Management's portfolio value fell 17% quarter-over-quarter to $123B.
Based on Primecap Management's 13F filing for Q4 2018, filed 12 Feb 2019.